Vol. 12. Núm. S2.
Páginas 20 (Junio 2005)

Tratamiento de las secuelas y rehabilitación

Opciones

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliograf¿a
[1]
Atención hospitalaria organizada (unidad de accidentes cerebrovasculares) para el accidente cerebrovascular. En: Cochrane Library plus en español. Oxford: Update Software; 2001.
[2]
Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-83.
[3]
European Stroke Initiative Recommendations for Stroke Management. Update 2003. Cerebrovasc Dis. 2003;16:311-37.
[4]
Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke. 1997;28:2126-32.
[5]
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology. 1998; 50:876-83.
[6]
Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-4.
[7]
Stroke. 1999;30:2033-7.
[8]
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002; 33:1315-20.
[9]
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-6.
[10]
Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-9.
[11]
Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410-4.
[12]
Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-7.
[13]
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-81.
[14]
Anticoagulants and antiplatelet agents in acute ischemic stroke. Stroke. 2002;33:1934-42.
[15]
Popularion based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326-8.
[16]
Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34:138-40.
[17]
Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-6.
[18]
Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170:1105-9.
[19]
Life alter stroke. New Zealand guidline for management of stroke. Best practice evidente guideline. November 2003 [citado 10 Jul 2004]. Disponible en: http://www.nzgg.org.nz
[20]
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999;30:1991-4.
[21]
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993; 342:1255-62.
[22]
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med. 1999;131:492-501.
[23]
Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet. 2004;363:915-24.
[24]
Guía de actuación clínica en el ataque isquémico transitorio [citado el 10 de agosto 2004]. Disponible en: http://www.sen.es/formacion/ictus/AITGuiadoc.htm
[25]
The Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
[26]
Stroke. Lancet. 2003;362:1211-24.
[27]
Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937-41.
[28]
Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232-6.
[29]
Smoking cessation and the risk of stroke in middle-aged men. JAMA. 1995;274:155-60.
[30]
Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. BMJ. 1999;3 19:943-7.
[31]
Post-stroke antihypertensive treatment study: a preliminary result. Clin Med J. 1995; 108:710-7.
[32]
Randomised trial of a perindopril-based bllod-pressure-lowering regimeng among 6.105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-41.
[33]
SPARCL Investigators. Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc Dis. 2003;16:389-95.
[34]
Effects of cholesterol- lowering on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other highrisk conditions. Lancet. 2004;363:757-67.
[35]
Statins after ischemic stroke and transient ischemic attack. Stroke. 2004;35:1023.
[36]
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-30.
[37]
Prevention of ischaemic stroke. BMJ. 2000;321:1455-9.
[38]
Comparison of triflusal and aspirin for prevention of vascular events inpatients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke. 2003;34:840-8.
[39]
A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-39.
[40]
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patientes undergoing percutaneus coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-33.
[41]
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): rendomised, double-blid, placebo-controled trial. Lancet. 2004;364:331-7.
[42]
New evidence for stroke prevention. Scientific review. JAMA. 2002;288:1388-95.
[43]
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med. 2003;139:1018-33.
[44]
Antithrombotic therapy in valvular heart disease. Chest. 2001;119:S207-19.
[45]
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation. 2003;107:1692-711.
[46]
Current and future concepts in stroke prevention, CMAJ. 2004;170:1123-33.
[47]
A comparison of warfarin and aspirin for the prevention of recurrent stroke. N Engl J Med. 2001; 345:1444-51.
[48]
Anticoagulation for preventing stroke in patientes with non-reumatic atrial fibrillation and a history of stroke or transient ischemic attack. Stroke. 2004; 35:1782-3.
[49]
Platelet-active drugs. The relationships among dose, effectiveness, and side effects. Chest. 2001;119:S39-63.
[50]
Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:S194-206.
[51]
Managements of patients with stroke. II: Management of carotid stenosis and carotid endarterectomy. A national clinical guideline. Edinburgh: Sing; 1997.
[52]
Endarterectomía carotídea para la estenosis carotídea sintomática. En: Cochcrane Library plus en español. Oxford: Update Software; 1999.
[53]
Lancet. 2001;357:1729-37.
[54]
Long-term outcome after angioplasty for symptomatic extracranial carotid stenosis in poor surgical candidates. Stroke. 2002;33:2877-80.
[55]
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-9.
[56]
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202-6.
[57]
Dietary intake of folate and risk of stroke un US men and women. NHANES I Epidemiologic Follow-Up Strudy. Stroke. 2002:33;1183-8.
[58]
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke. Myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) Randomised Controlled Trial. JAMA. 2004; 291:565-75.
[59]
Folate and the risk of stroke: fortify first and ask questions later? Stroke. 2002;33:1188-9.
[60]
Antithrombotic therapy for atrial fibrillation. BMJ. 2002;325:1022-5.
[61]
The development and use of a method to compare the costs of acute stroke across Europe. Age Ageing. 2001;30:67-72.
[62]
El coste del ictus. Anales Sis San Navarra. 2000;23 Supl 3:33-8.
[63]
Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.Lancet. 1999;354:1457-63.
[64]
Rentabilidad de la prevención del accidente cerebrovascular. En: Brown M, editor. Accidente cerebrovascular. Barcelona: Medical Trends; 2001. p. 193-207.
[65]
Cost of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease. Throm Haemost. 2001;85:52-6.
[66]
Is carotid angioplasty and stenting more cost effective than carotid endarterectomy? J Vasc Surg. 2003; 37:331-9.
[67]
Enfermedad cerebrovascular en atención primaria. El Médico. 2002;133:23-46.
[68]
¿Qué hacer después de un ictus? FMC. 2000;7:601-8.
[69]
Patología neurológica. En: Martín Zurro A, Cano Pérez JF, editores. Atención primaria. Conceptos, organización y práctica clínica. 5.ª ed. Madrid: Elsevier; 2003. p. 1288-316.
[70]
Effective physiotheraty. BMJ. 2001;323:788-90.
[71]
Enfermedad vascular cerebral (y II). El Médico. 2001;282:31-54.
[72]
Después del ictus. Guía práctica para el paciente y sus cuidadores. Barcelona: EdiDe; 1997.
[73]
Managements of patients with stroke. Rehabilitation, prevention and management of complications and discharge planning. A national clinical guideline. Edinburgh: Sing; 2002.
[74]
National Clinical Guidelines for Stroke. Update 2002. Suffolk: Lavenham Press; 2002.
[75]
Guía clínica de Ictus [citado 10 Jul 2004]. Disponible en: http://www.fisterra.com/guias2/ictus.htm
[76]
Interventions for treating depression after stroke (Cochrane Review). En: The Cochrane Library, Issue 3. Chichester: John Wiley and Sons; 2004.
[77]
Terapia del habla y lenguaje para la afasia después de un accidente cerebrovascular. En: Cochrane Library plus en español. Oxford: Update Software; 1999.
[78]
Servicios de rehabilitación basados en terapias para pacientes con accidente cerebrovascular que viven en sus domicilios. En: Cochrane Library plus en español. Oxford: Update Software.
[79]
Enfoques del tratamiento fisioterápico para la recuperación del control postural y la función del miembro inferior después de un accidente cerebrovascular. En: Cochcrane Library plus en español. Oxford: Update Software.
[80]
Entrenamiento con ejercicios físicos para pacientes con accidente cerebrovascular. En: Cochcrane Library plus en español. Oxford: Update Software; 2003.
[81]
Evaluation and treatment of central pain síndromes. Neurology. 2004;62 Supl 2:S30-6.
[82]
Training carers of stroke patients. Randomised controlled trial. BMJ. 2004;328:1099-101.
[83]
Enfermedad cerebrovascular. En: Marín Iranzo R, Álvarez Cosmea A, editores. Enfermedad vascular: prevención secundaria desde la atención primaria. Oviedo: Sociedad Asturiana de Hipertensión y Riesgo Vascular; 2002. p. 41-9.